Table 2.
COC Urinary | ||||
---|---|---|---|---|
Variables | Rate (%) | OR | P-value | |
Sex | Men (ref.) | 10.5 | 2.65 | <0.0001 |
Age (years) | 18–64 (ref.) | 9.0 | ||
65–74 | 12.6 | 1.47 | 0.011 | |
75–84 | 22.2 | 2.9 | <0.0001 | |
Above 85 | 27.5 | 3.84 | <0.0001 | |
Severity of T2DM | Stage 1 (ref.) | 24.4 | ||
Stage 2 | 4.8 | 0.16 | <0.0001 | |
Stage 3 | 24.7 | 1.02 | 0.9445 | |
Comorbidities | NUT82 (ref.) | 14.6 | ||
CVS13 | 21.5 | 1.6 | 0.0005 | |
NUT02 | 16.8 | 1.18 | 0.2614 | |
CVS11 | 14.8 | 1.02 | 0.9266 | |
NEU04 | 22.7 | 1.72 | 0.0008 | |
CVS09 | 20.7 | 1.52 | 0.0423 | |
RES15 | 24.6 | 1.91 | 0.0006 | |
GUS08 | 23.1 | 1.76 | 0.0034 | |
RES83 | 25.5 | 2.01 | 0.0003 | |
RES24 | 18.5 | 1.32 | 0.4 | |
GIS27 | 28.2 | 2.29 | 0.0031 | |
RES13 | 8.3 | 0.53 | 0.5468 | |
GIS30 | 12.5 | 0.84 | 0.8133 | |
Treatment type | Surgical (ref.) | 4.8 | 6.52 | <0.0001 |
Medical | 24.6 |
COC Urinary, urinary tract infection after procedure; NUT82, lipid abnormalities; CVS13, essential hypertension; NUT02, obesity; CVS11, coronary artery disease without prior coronary revascularization; NEU04, cerebrovascular disease; CVS09, congestive heart failure; RES15, pneumonia: bacterial; GUS08, renal failure; RES83, other disorders of the respiratory system; RES24, rhino, adeno, and corona virus infections; GIS27, neoplasm, malignant: colon and rectum; RES13, neoplasm, malignant: lungs, bronchi, or mediastinum; GIS30, neoplasm, malignant: stomach. Rate (%) = Total number of patients with infection/sum of patient at risk without infection and at risk with infection *100, Abbreviation: T2DM, type 2 of diabetes mellitus; OR, odds ratio; ref., reference group.